Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Operating Income Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual operating income in 2023 was -1.04 Million USD , down -6.31% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly operating income in 2023 Q4 was -527.2 Thousand USD , down -200.53% from previous quarter.
Vicapsys Life Sciences, Inc. reported an annual operating income of -984.79 Thousand USD in 2022, down -192.33% from previous year.
Vicapsys Life Sciences, Inc. reported an annual operating income of -336.87 Thousand USD in 2021, up 56.01% from previous year.
Vicapsys Life Sciences, Inc. reported a quarterly operating income of -211.27 Thousand USD for 2023 Q1, up 57.11% from previous quarter.
Vicapsys Life Sciences, Inc. reported a quarterly operating income of -175.42 Thousand USD for 2023 Q3, down -29.28% from previous quarter.

Annual Operating Income Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Operating Income of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	Operating Income	Operating Income Growth
2023	-1.04 Million USD	-6.31%
2022	-984.79 Thousand USD	-192.33%
2021	-336.87 Thousand USD	56.01%
2020	-765.84 Thousand USD	25.93%
2019	-1.03 Million USD	19.51%
2018	-1.28 Million USD	60.28%
2017	-3.23 Million USD	0.0%
2009	-1.35 Million USD	42.63%
2008	-2.35 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2023 Q4	-527.2 Thousand USD	-200.53%
2023 Q1	-211.27 Thousand USD	57.11%
2023 Q3	-175.42 Thousand USD	-29.28%
2023 Q2	-135.69 Thousand USD	35.77%
2022 FY	-984.79 Thousand USD	-192.33%
2022 Q2	-180.05 Thousand USD	-7.79%
2022 Q3	-145.08 Thousand USD	19.42%
2022 Q4	-492.6 Thousand USD	-239.54%
2022 Q1	-167.04 Thousand USD	-60.84%
2021 Q2	-72.06 Thousand USD	-44.79%
2021 FY	-336.87 Thousand USD	56.01%
2021 Q4	-103.85 Thousand USD	6.59%
2021 Q3	-111.18 Thousand USD	-54.29%
2021 Q1	-49.77 Thousand USD	38.21%
2020 Q3	-89.22 Thousand USD	61.48%
2020 Q2	-231.61 Thousand USD	36.45%
2020 FY	-765.84 Thousand USD	25.93%
2020 Q1	-364.45 Thousand USD	-46.0%
2020 Q4	-80.54 Thousand USD	9.72%
2019 Q2	-151.34 Thousand USD	7.49%
2019 FY	-1.03 Million USD	19.51%
2019 Q4	-249.63 Thousand USD	46.81%
2019 Q3	-469.34 Thousand USD	-210.12%
2019 Q1	-163.59 Thousand USD	-95.08%
2018 Q4	-83.86 Thousand USD	0.0%
2018 FY	-1.28 Million USD	60.28%
2017 FY	-3.23 Million USD	0.0%
2010 Q1	-623.62 Thousand USD	-40693.42%
2010 Q2	-1.37 Million USD	-120.51%
2009 FY	-1.35 Million USD	42.63%
2009 Q4	-1528.73 USD	0.0%
2009 Q2	-486.79 Thousand USD	-68.34%
2009 Q1	-289.17 Thousand USD	0.0%
2008 FY	-2.35 Million USD	0.0%

Peer Operating Income Comparison of Vicapsys Life Sciences, Inc.

Name	Operating Income	Operating Income Difference
America Great Health	-492.64 Thousand USD	-112.522%
Gene Biotherapeutics, Inc.	- USD	Infinity%
Evolutionary Genomics, Inc.	-2.01 Million USD	48.023%
Innovation1 Biotech Inc.	-1.36 Million USD	23.432%
Point of Care Nano-Technology, Inc.	-78.01 Thousand USD	-1241.987%